Drugs

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Drugs

Merck announces positive results for KEYNOTE-756

Photo from Paolo Tarantino/Twitter

Jul 30, 2023, 06:33

Merck announces positive results for KEYNOTE-756

In a post by Paolo Tarantino on Twitter, it says, “Merck announces positive results for KEYNOTE-756: the addition of pembrolizumab to neoadjuvant chemo significantly improved pCR rate among patients with high-risk HR+/HER2- breast cancer. Follow up ongoing for EFS (co-primary endpoint).”

For the article: Click here
Source:Paolo Tarantino / Twitter

Breast Cancer cancer Merck Neoadjuvant OncoDaily Oncology Paolo Tarantino pembrolizumab

Sep 7, 2024, 12:05

Myeloma Paper of the Day, September 7th, suggested by Robert Orlowski

Sep 7, 2024, 11:53

OncoInfluencers to Follow on Social Media: Dr. Aman Chauhan

Sep 7, 2024, 11:44

Toni Choueiri: Celebrating Matt Freedman, the new David Goldstein Chair at Dana-Farber Cancer Institute

Sep 7, 2024, 11:19

Meet the speakers of CityU - AFCR Symposium - Leslie Leinwand

Sep 7, 2024, 11:16

Paolo Tarantino: Recommended read on adjuvant ribociclib in preparation for the ESMO24

Sep 7, 2024, 10:25

2024 Lunch and Learn Series: Initial Steps for Navigating a Rare Cancer Diagnosis - TargetCancer Foundation

Sep 7, 2024, 10:22

Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer

Sep 7, 2024, 10:18

AFCR announces the winners of the 2024 BRACE Award Venture Competition

Sep 7, 2024, 10:15

Leo Meriranta: KLHL6 targeting the B-cell receptor and lymphoma mutations

Sep 7, 2024, 10:14

Submission deadline extended for Special LMIC collection at IPOS’ official journal

Sep 7, 2024, 10:11

Cancer-Related Fatigue in Patients and Survivors of Lymphoma by Steve Kalloger et al.

Sep 7, 2024, 10:09

D.Cristina Stefan: The heartbeat of hope, the hands of healing